Hepatic oxidant/antioxidant status in cholesterol-fed rabbits: Effects of garlic extract

Hepatology Research

Volumn 39, Issue 1, 2009, Pages 70-77

  Arhan, Mehmet ^a,d   Öztürk, H Serdar ^a   Turhan, Nesrin ^b   Aytac, Bilal ^a   Güven, M Cengiz ^a   Olcay, Ekmel ^c   Durak, Ilker ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^c Department of Pharmacology   (Turkey)

^d Yunus Emre Caddesi   (Turkey)

Author keywords

Cholesterol; Garlic; Liver; Steatosis

Indexed keywords

CATALASE; CHOLESTEROL; GARLIC EXTRACT; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIETARY INTAKE; DRUG ISOLATION; DRUG MECHANISM; DRUG RESPONSE; ENZYME ACTIVITY; FATTY LIVER; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 58149191275     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00401.x     Document Type: Article

References (49)

1. Neuschwander-Tetri B, Caldwell S. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19.
2. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
3. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Current pharmacological treatment of nonalcohololic fatty liver. Curr Med Chem 2006; 13: 2889-90.
4. Suzuki A, Lindor K, St Saver J et al. Effect of changes on body weight and lifestyle in nonalcohololic fatty liver disease. J Hepatol 2005; 43: 1060-6.
5. Fiatarone JR, Coverdale SA, Batey RG, Farrell GC. Non-alcoholic steatohepatitis: Impaired antipyrine metabolism and hypertriglyceridaemia may be clues to its pathogenesis. J Gastroenterol Hepatol 1991; 6: 585-90.
6. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 12: 1106-10.
7. Berson A, De Beco V, Lettéron P et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes. Gastroenterology 1998; 114: 764-74.
8. Letteron P, Fromenty B, Terris B, Degott C, Pessayre D. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. J Hepatol 1996; 24: 200-8.
9. Pinto HC, De Moura MC, Day CP. Non-alcoholic steatohepatitis: From cell biology to clinical practice. J Hepatol 2006; 44: 197-208.
10. Day CP, James OFW. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998; 114: 842-5.
11. Weltmann MD, Liddle C, Farrell GC. Hepatic CYP2E1 is increased in patients with non-alcoholic steatohepatitis (abstr). Hepatology 1996; 24: 202A.
12. Weltmann MD, Farrell GC, Liddle C. Increased CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-53.
13. Zangar RC, Novak RF. Effects of fatty acids and ketone bodies on cytochromes P450 2B, 4A, and 2E1 expression in primary cultured rat hepatocytes. Arch Biochem Biophys 1997; 337: 217-24.
14. Takahashi H, Johansson I, French SW, Ingelman-Sundberg M. Effects of dietary fat composition on activities of the microsomal ethanol oxidizing system and ethanol-inducible cytochrom P-450 (CYP 2E1) in the liver of rats chronically fed ethanol. Pharmacol Toxicol 1992; 70: 347-51.
15. George DK, Goldwurm S, Macdonald GA et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998; 114: 311-18.
16. Gedik N, Kabasakal L, Sehirli O et al. Long-term administration of aqueous garlic extract (AGE) alleviates liver fibrosis and oxidative damage induced by biliary obstruction in rats. Life Sci 2005; 76: 2593-606.
17. Durak I, Kavutcu M, Aytac B et al. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem 2004; 15: 373-7.
18. Thomson M, Al-Qattan KK, Bordia T, Ali M. Including garlic in the diet may help lower blood glucose, cholesterol, and triglycerides. J Nutr 2006; 136 (Suppl 3): 800-2.
19. Singh DK, Porter TD. Inhibition of sterol 4alpha-methyl oxidase is the principal mechanism by which garlic decreases cholesterol synthesis. J Nutr 2006; 136 (Suppl 3): 759-64.
20. Gorinstein S, Leontowicz H, Leontowicz M et al. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci 2006; 78: 655-63.
21. Durak I, Ozturk HS, Olcay E, Can B, Kavutcu M. Effects of garlic extract supplementation on blood lipid and antioxidant parameters and atherosclerotic plaque formation process in cholesterol-fed rabbits. Nutr Metab Cardiovasc Dis 2002; 12: 141-7.
22. Durak I, Canbolat O, Kavutcu M, Öztürk HS, Yurtarslani Z. Activities of total, cytoplasmic and mitochondrial superoxide dismutase enzymes in sera and pleural fluids from patients with lung cancer. J Clin Lab Anal 1996; 10: 17-20.
23. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-69.
24. Aebi H. Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: Academic Press, 1974; 673-77.
25. Durak I, Karabacak HI, Büyükkoçak S et al. Impaired antioxidant defence system in the kidney tissues from rabbits treated with cyclosporine: Protective effects of vitamins E and C. Nephron 1998; 78: 207-11.
26. Dahle LK, Hill EG, Hollman RT. The thiobarbituric acid reaction and the autoxidations of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 1962; 98: 253-61.
27. Lowry O, Rosenbrough N, Farr L, Randall R. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-75.
28. Lieber CS. Biochemical and molecular basis of alcoholic-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639-50.
29. Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetes mellitus. Gastroenterology 1980; 78: 535-41.
30. Fromenty B, Fisch C, Labbe G et al. Amiodarone inhibits the mitochondrial oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther 1990; 255: 1371-6.
31. Labbe G, Fromenty B, Fréneaux E et al. Effects of various tetracycline derivatives on in vitro and in vivo oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice. Biochem Pharmacol 1991; 41: 638-41.
32. Sulyok S, Bar-Pollak Z, Feher E, Kemenes I, Kantor I, Feher J. Liver lipid peroxidation induced by cholesterol and its treatment with a dihydroquinoline type free radical scavenger in rabbits. Acta Physiol Hung 1984; 64: 437-42.
33. Fungwe TV, Cagen LM, Wilcox HG, Heimberg M. Effects of dietary cholesterol on hepatic metabolism of free fatty acid and secretion of VLDL in the hamster. Biochem Biophys Res Commun 1994; 16: 1505-11.
34. Fromenty B, Berson A, Pessayre D. Microvesicular steatosis and steatohepatitis: Role of mitochondrial dysfunction and lipid peroxidation. J Hepatol 1997; 26: 13-22.
35. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol 1995; 23: 16-24.
36. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 2008; 29 (1-2): 9-16.
37. Berson A, Renault S, Lettéron P et al. Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction. Gastroenterology 1996; 110: 1878-90.
38. Fau D, Eugéne D, Berson A et al. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes. J Pharmacol Exp Ther 1994; 269: 954-62.
39. Fau D, Berson A, Eugéne D, Fromenty B, Fisch C, Pessayre D. Mechanism for the hepatotoxicity of the antiandrogen, nilutamide. Evidence suggesting that redox cycling of this nitroaromatic drug leads to oxidative stress in isolated hepatocytes. J Pharmacol Exp Ther 1992; 263: 69-77.
40. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. Hepatic cytochome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 1998; 27: 128-33.
41. Kainuma M, Fujimoto M, Sekiya N et al. Cholesterol-fed rabbit as a unique model of nonalcoholic, nonobese, non-insulin-resistant fatty liver disease with characteristic fibrosis. J Gastroenterol 2006; 41: 971-80.
42. Diehl AM, Goodman Z, Ihsak KG. Alcohol-like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1065-62.
43. Mofrad P, Contos MJ, Haque M et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003; 37: 1286-92.
44. Sumioka I, Hayama M, Shimokawa Y, Shiraishi S, Tokunaga A. Lipid-lowering effect of monascus garlic fermented extract (MGFE) in hyperlipidemic subjects. Hiroshima J Med Sci 2006; 55: 59-64.
45. Gebhardt R, Beck H. Differential inhibitory effects of garlic-derived organosulfur compounds on cholesterol biosynthesis in primary rat hepatocyte cultures. Lipids 1996; 1269-76.
46. Sener G, Sehirli O, Ipci Y et al. Aqueous garlic extract alleviates ischaemia - reperfusion-induced oxidative hepatic injury in rats. J Pharm Pharmacol 2005; 57: 145-50.
47. Vimal V, Devaki T. Hepatoprotective effect of allicin on tissue defense system in galactosamine/endotoxin challenged rats. J Ethnopharmacol 2004; 90: 151-4.
48. Velmurugan B, Bhuvaneswari V, Nagini S. Effect of S-allylcysteine on oxidant-antioxidant status during N-methyl-N′-nitro-N-nitrosoguanidine and saturated sodium chloride-induced gastric carcinogenesis in Wistar rats. Asia Pac J Clin Nutr 2003; 12: 488-94.
49. Banerjee SK, Mukherjee PK, Maulik SK. Garlic as an antioxidant: The good, the bad and the ugly. Phytother Res 2003; 17 (2): 97-106.